Published in Genetics on January 01, 2001
Identification of a human decapping complex associated with hUpf proteins in nonsense-mediated decay. Mol Cell Biol (2002) 5.80
The DEAD box helicase, Dhh1p, functions in mRNA decapping and interacts with both the decapping and deadenylase complexes. RNA (2001) 4.80
The control of mRNA decapping and P-body formation. Mol Cell (2008) 3.58
The yeast POP2 gene encodes a nuclease involved in mRNA deadenylation. Nucleic Acids Res (2001) 2.76
Function of the ski4p (Csl4p) and Ski7p proteins in 3'-to-5' degradation of mRNA. Mol Cell Biol (2000) 2.71
The DEAD box protein Dhh1 stimulates the decapping enzyme Dcp1. EMBO J (2002) 2.65
Analysis of recombinant yeast decapping enzyme. RNA (2003) 2.50
P-bodies and stress granules: possible roles in the control of translation and mRNA degradation. Cold Spring Harb Perspect Biol (2012) 2.19
Arabidopsis DCP2, DCP1, and VARICOSE form a decapping complex required for postembryonic development. Plant Cell (2006) 2.13
RNA degradation in Saccharomyces cerevisae. Genetics (2012) 2.06
Decapping activators in Saccharomyces cerevisiae act by multiple mechanisms. Mol Cell (2010) 1.93
Lsm1 promotes genomic stability by controlling histone mRNA decay. EMBO J (2011) 1.73
The yeast cytoplasmic LsmI/Pat1p complex protects mRNA 3' termini from partial degradation. Genetics (2001) 1.57
Crystal structure of Dcp1p and its functional implications in mRNA decapping. Nat Struct Mol Biol (2004) 1.57
The decapping activator Lsm1p-7p-Pat1p complex has the intrinsic ability to distinguish between oligoadenylated and polyadenylated RNAs. RNA (2007) 1.54
The yeast EDC1 mRNA undergoes deadenylation-independent decapping stimulated by Not2p, Not4p, and Not5p. EMBO J (2005) 1.47
YRA1 autoregulation requires nuclear export and cytoplasmic Edc3p-mediated degradation of its pre-mRNA. Mol Cell (2007) 1.43
The enhancer of decapping proteins, Edc1p and Edc2p, bind RNA and stimulate the activity of the decapping enzyme. RNA (2003) 1.39
The target of rapamycin signaling pathway regulates mRNA turnover in the yeast Saccharomyces cerevisiae. Mol Biol Cell (2001) 1.27
Mutations in the Saccharomyces cerevisiae LSM1 gene that affect mRNA decapping and 3' end protection. Genetics (2005) 1.23
Structural and functional control of the eukaryotic mRNA decapping machinery. Biochim Biophys Acta (2012) 1.23
mRNA decay enzymes: decappers conserved between yeast and mammals. Proc Natl Acad Sci U S A (2002) 1.22
A split active site couples cap recognition by Dcp2 to activation. Nat Struct Mol Biol (2010) 1.12
Identification and analysis of the interaction between Edc3 and Dcp2 in Saccharomyces cerevisiae. Mol Cell Biol (2010) 1.10
Sbp1p affects translational repression and decapping in Saccharomyces cerevisiae. Mol Cell Biol (2006) 1.09
Dcp2 Decaps m2,2,7GpppN-capped RNAs, and its activity is sequence and context dependent. Mol Cell Biol (2005) 1.08
Dcp1 links coactivators of mRNA decapping to Dcp2 by proline recognition. RNA (2010) 1.04
Genetic background affects relative nonsense mRNA accumulation in wild-type and upf mutant yeast strains. Curr Genet (2003) 1.04
RNA decay modulates gene expression and controls its fidelity. Wiley Interdiscip Rev RNA (2011) 0.98
Evolutionary conservation supports ancient origin for Nudt16, a nuclear-localized, RNA-binding, RNA-decapping enzyme. Nucleic Acids Res (2008) 0.97
lsm1 mutations impairing the ability of the Lsm1p-7p-Pat1p complex to preferentially bind to oligoadenylated RNA affect mRNA decay in vivo. RNA (2008) 0.96
Ebs1p, a negative regulator of gene expression controlled by the Upf proteins in the yeast Saccharomyces cerevisiae. Eukaryot Cell (2006) 0.96
Interdomain dynamics and coactivation of the mRNA decapping enzyme Dcp2 are mediated by a gatekeeper tryptophan. Proc Natl Acad Sci U S A (2012) 0.94
Intermolecular interactions within the abundant DEAD-box protein Dhh1 regulate its activity in vivo. J Biol Chem (2011) 0.94
Quality control of assembly-defective U1 snRNAs by decapping and 5'-to-3' exonucleolytic digestion. Proc Natl Acad Sci U S A (2014) 0.93
Interactions between Upf1 and the decapping factors Edc3 and Pat1 in Saccharomyces cerevisiae. PLoS One (2011) 0.91
Analysis of the products of mRNA decapping and 3'-to-5' decay by denaturing gel electrophoresis. RNA (2002) 0.90
Structure of the Dcp2-Dcp1 mRNA-decapping complex in the activated conformation. Nat Struct Mol Biol (2016) 0.89
H2B ubiquitylation is part of chromatin architecture that marks exon-intron structure in budding yeast. BMC Genomics (2011) 0.88
Enhancer of decapping proteins 1 and 2 are important for translation during heat stress in Saccharomyces cerevisiae. Mol Microbiol (2009) 0.85
Structural basis of mRNA-cap recognition by Dcp1-Dcp2. Nat Struct Mol Biol (2016) 0.82
The S. pombe mRNA decapping complex recruits cofactors and an Edc1-like activator through a single dynamic surface. RNA (2016) 0.79
Proteomic Analysis of Dhh1 Complexes Reveals a Role for Hsp40 Chaperone Ydj1 in Yeast P-Body Assembly. G3 (Bethesda) (2015) 0.76
Use of Cellular Decapping Activators by Positive-Strand RNA Viruses. Viruses (2016) 0.75
Changes in conformational equilibria regulate the activity of the Dcp2 decapping enzyme. Proc Natl Acad Sci U S A (2017) 0.75
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
A turnover pathway for both stable and unstable mRNAs in yeast: evidence for a requirement for deadenylation. Genes Dev (1993) 9.28
The exosome: a conserved eukaryotic RNA processing complex containing multiple 3'-->5' exoribonucleases. Cell (1997) 8.94
mRNA stability in mammalian cells. Microbiol Rev (1995) 8.78
Deadenylation of the unstable mRNA encoded by the yeast MFA2 gene leads to decapping followed by 5'-->3' digestion of the transcript. Genes Dev (1994) 7.57
Interrelationships of the pathways of mRNA decay and translation in eukaryotic cells. Annu Rev Biochem (1996) 7.08
Yeast cells lacking 5'-->3' exoribonuclease 1 contain mRNA species that are poly(A) deficient and partially lack the 5' cap structure. Mol Cell Biol (1993) 6.36
An essential component of the decapping enzyme required for normal rates of mRNA turnover. Nature (1996) 6.15
Premature translational termination triggers mRNA decapping. Nature (1994) 6.05
Yeast Sm-like proteins function in mRNA decapping and decay. Nature (2000) 5.95
The MutT proteins or "Nudix" hydrolases, a family of versatile, widely distributed, "housecleaning" enzymes. J Biol Chem (1996) 5.08
The DCP2 protein is required for mRNA decapping in Saccharomyces cerevisiae and contains a functional MutT motif. EMBO J (1999) 5.08
A Sm-like protein complex that participates in mRNA degradation. EMBO J (2000) 5.08
A mouse cytoplasmic exoribonuclease (mXRN1p) with preference for G4 tetraplex substrates. J Cell Biol (1997) 4.93
Mutations in translation initiation factors lead to increased rates of deadenylation and decapping of mRNAs in Saccharomyces cerevisiae. Mol Cell Biol (1999) 4.35
Mechanisms and control of mRNA turnover in Saccharomyces cerevisiae. Microbiol Rev (1996) 4.34
A small segment of the MAT alpha 1 transcript promotes mRNA decay in Saccharomyces cerevisiae: a stimulatory role for rare codons. Mol Cell Biol (1993) 3.91
Sm and Sm-like proteins assemble in two related complexes of deep evolutionary origin. EMBO J (1999) 3.68
Mutations in trans-acting factors affecting mRNA decapping in Saccharomyces cerevisiae. Mol Cell Biol (1996) 3.58
Messenger RNA deadenylylation precedes decapping in mammalian cells. Proc Natl Acad Sci U S A (1997) 3.51
Isolation and characterization of Dcp1p, the yeast mRNA decapping enzyme. EMBO J (1998) 2.82
Capped mRNA degradation intermediates accumulate in the yeast spb8-2 mutant. Mol Cell Biol (1998) 2.79
Function of the ski4p (Csl4p) and Ski7p proteins in 3'-to-5' degradation of mRNA. Mol Cell Biol (2000) 2.71
Characterization of cis-acting sequences and decay intermediates involved in nonsense-mediated mRNA turnover. Mol Cell Biol (1995) 2.55
The rate-limiting step in yeast PGK1 mRNA degradation is an endonucleolytic cleavage in the 3'-terminal part of the coding region. Mol Cell Biol (1992) 2.27
A quantitative analysis of the effects of 5' junction and TACTAAC box mutants and mutant combinations on yeast mRNA splicing. Cell (1985) 2.14
Analysis of mutations in the yeast mRNA decapping enzyme. Genetics (1999) 1.93
A dual role for BBP/ScSF1 in nuclear pre-mRNA retention and splicing. EMBO J (2000) 1.76
A highly conserved sequence motif defining the family of MutT-related proteins from eubacteria, eukaryotes and viruses. Nucleic Acids Res (1993) 1.49
Human helicase gene SKI2W in the HLA class III region exhibits striking structural similarities to the yeast antiviral gene SKI2 and to the human gene KIAA0052: emergence of a new gene family. Nucleic Acids Res (1995) 1.37
Identification and characterization of a human cDNA homologous to yeast SKI2. Genomics (1995) 1.27
Analysis of mRNA decay pathways in Saccharomyces cerevisiae. Methods (1999) 0.86
A turnover pathway for both stable and unstable mRNAs in yeast: evidence for a requirement for deadenylation. Genes Dev (1993) 9.28
A rapid method for localized mutagenesis of yeast genes. Yeast (1992) 7.79
The Regenstrief Medical Record System: a quarter century experience. Int J Med Inform (1999) 7.68
Deadenylation of the unstable mRNA encoded by the yeast MFA2 gene leads to decapping followed by 5'-->3' digestion of the transcript. Genes Dev (1994) 7.57
Degradation of mRNA in eukaryotes. Cell (1995) 6.81
An essential component of the decapping enzyme required for normal rates of mRNA turnover. Nature (1996) 6.15
Recognition of the TACTAAC box during mRNA splicing in yeast involves base pairing to the U2-like snRNA. Cell (1987) 6.08
Premature translational termination triggers mRNA decapping. Nature (1994) 6.05
Yeast Sm-like proteins function in mRNA decapping and decay. Nature (2000) 5.95
The transcription factor associated Ccr4 and Caf1 proteins are components of the major cytoplasmic mRNA deadenylase in Saccharomyces cerevisiae. Cell (2001) 5.86
Turnover mechanisms of the stable yeast PGK1 mRNA. Mol Cell Biol (1995) 5.83
Identification and comparison of stable and unstable mRNAs in Saccharomyces cerevisiae. Mol Cell Biol (1990) 5.47
The DCP2 protein is required for mRNA decapping in Saccharomyces cerevisiae and contains a functional MutT motif. EMBO J (1999) 5.08
The DEAD box helicase, Dhh1p, functions in mRNA decapping and interacts with both the decapping and deadenylase complexes. RNA (2001) 4.80
Yeast exosome mutants accumulate 3'-extended polyadenylated forms of U4 small nuclear RNA and small nucleolar RNAs. Mol Cell Biol (2000) 4.57
Mutations in translation initiation factors lead to increased rates of deadenylation and decapping of mRNAs in Saccharomyces cerevisiae. Mol Cell Biol (1999) 4.35
Mechanisms and control of mRNA turnover in Saccharomyces cerevisiae. Microbiol Rev (1996) 4.34
Mutations affecting stability and deadenylation of the yeast MFA2 transcript. Genes Dev (1992) 4.20
Multiple functions for the poly(A)-binding protein in mRNA decapping and deadenylation in yeast. Genes Dev (1995) 4.15
Targeting an mRNA for decapping: displacement of translation factors and association of the Lsm1p-7p complex on deadenylated yeast mRNAs. Mol Cell (2001) 4.12
A small segment of the MAT alpha 1 transcript promotes mRNA decay in Saccharomyces cerevisiae: a stimulatory role for rare codons. Mol Cell Biol (1993) 3.91
Quality control of mRNA 3'-end processing is linked to the nuclear exosome. Nature (2001) 3.69
Mutations in trans-acting factors affecting mRNA decapping in Saccharomyces cerevisiae. Mol Cell Biol (1996) 3.58
The Puf3 protein is a transcript-specific regulator of mRNA degradation in yeast. EMBO J (2000) 3.38
Differential effects of translational inhibition in cis and in trans on the decay of the unstable yeast MFA2 mRNA. J Biol Chem (1994) 3.37
Mutations in conserved intron sequences affect multiple steps in the yeast splicing pathway, particularly assembly of the spliceosome. EMBO J (1986) 3.35
mRNA decapping in yeast requires dissociation of the cap binding protein, eukaryotic translation initiation factor 4E. Mol Cell Biol (2000) 3.06
Mechanisms of mRNA degradation in eukaryotes. Trends Biochem Sci (1994) 2.96
Survival with the acquired immunodeficiency syndrome. Experience with 5833 cases in New York City. N Engl J Med (1987) 2.91
Isolation and characterization of Dcp1p, the yeast mRNA decapping enzyme. EMBO J (1998) 2.82
Mechanisms of mRNA surveillance in eukaryotes. Annu Rev Genet (1999) 2.73
The exosome: a proteasome for RNA? Cell (1999) 2.72
Function of the ski4p (Csl4p) and Ski7p proteins in 3'-to-5' degradation of mRNA. Mol Cell Biol (2000) 2.71
Prevention of premature birth by screening and treatment for common genital tract infections: results of a prospective controlled evaluation. Am J Obstet Gynecol (1995) 2.69
Oxaliplatin, tetraplatin, cisplatin, and carboplatin: spectrum of activity in drug-resistant cell lines and in the cell lines of the National Cancer Institute's Anticancer Drug Screen panel. Biochem Pharmacol (1996) 2.67
Mechanisms and control of mRNA decapping in Saccharomyces cerevisiae. Annu Rev Biochem (2000) 2.66
Changes in tonsillectomy rates associated with feedback and review. Pediatrics (1977) 2.60
Cancer in patients with ataxia-telangiectasia and in their relatives in the nordic countries. J Natl Cancer Inst (2001) 2.59
Pregnancy-related mortality in the United States, 1987-1990. Obstet Gynecol (1996) 2.57
A point mutation in the conserved hexanucleotide at a yeast 5' splice junction uncouples recognition, cleavage, and ligation. Cell (1985) 2.56
The UK colorectal cancer screening pilot: results of the second round of screening in England. Br J Cancer (2007) 2.48
Three conserved members of the RNase D family have unique and overlapping functions in the processing of 5S, 5.8S, U4, U5, RNase MRP and RNase P RNAs in yeast. EMBO J (2000) 2.44
Analysis of the yeast genome: identification of new non-coding and small ORF-containing RNAs. Nucleic Acids Res (1997) 2.40
Why don't patients do their exercises? Understanding non-compliance with physiotherapy in patients with osteoarthritis of the knee. J Epidemiol Community Health (2001) 2.26
Measurement of mRNA decay rates in Saccharomyces cerevisiae. Methods Enzymol (1991) 2.17
Aberrant mRNAs with extended 3' UTRs are substrates for rapid degradation by mRNA surveillance. RNA (1999) 2.15
Multifollicular ovaries: clinical and endocrine features and response to pulsatile gonadotropin releasing hormone. Lancet (1986) 2.14
Functions of Lsm proteins in mRNA degradation and splicing. Curr Opin Cell Biol (2000) 2.14
Diversity of cytoplasmic functions for the 3' untranslated region of eukaryotic transcripts. Curr Opin Cell Biol (1995) 2.06
A trans-acting suppressor restores splicing of a yeast intron with a branch point mutation. Genes Dev (1987) 1.99
Chemotherapy plus local treatment in the management of intraocular retinoblastoma. Arch Ophthalmol (1996) 1.95
Analysis of mutations in the yeast mRNA decapping enzyme. Genetics (1999) 1.93
mRNA surveillance in eukaryotes: kinetic proofreading of proper translation termination as assessed by mRNP domain organization? RNA (1999) 1.89
Recognition of yeast mRNAs as "nonsense containing" leads to both inhibition of mRNA translation and mRNA degradation: implications for the control of mRNA decapping. Mol Biol Cell (1999) 1.88
Functional evaluation following microvascular oromandibular reconstruction of the oral cancer patient: a comparative study of reconstructed and nonreconstructed patients. Laryngoscope (1991) 1.85
Separation of the mixture of trehalose 6,6'-dimycolates comprising the mycobacterial glycolipid fraction, "P3". Biochem Biophys Res Commun (1977) 1.82
Computational modeling of eukaryotic mRNA turnover. RNA (2001) 1.79
The conversion of 4-hydroxypyrazolo[3,4-d]pyrimidine (allopurinol) into 4,6-dihroxypyrazolo[3,4-d]pyrimidine (Oxipurinol) in vivo in the absence of xanthine-oxen oxidoreductase. Biochem J (1969) 1.76
Defects in the mRNA export factors Rat7p, Gle1p, Mex67p, and Rat8p cause hyperadenylation during 3'-end formation of nascent transcripts. RNA (2001) 1.71
The role of digital imaging and communications in medicine in an evolving healthcare computing environment: the model is the message. J Digit Imaging (1998) 1.70
Detection of Trichomonas vaginalis in pregnant women with the InPouch TV culture system. J Clin Microbiol (1993) 1.68
Treatment-related chromosome abnormalities in human embryos. Hum Reprod (1997) 1.65
Time trends in incidence rates of first hip fracture in the Uppsala Health Care Region, Sweden, 1965-1983. Am J Epidemiol (1989) 1.62
The kin-cohort study for estimating penetrance. Am J Epidemiol (1998) 1.60
The medical management of a heroin epidemic. Arch Gen Psychiatry (1972) 1.59
The yeast cytoplasmic LsmI/Pat1p complex protects mRNA 3' termini from partial degradation. Genetics (2001) 1.57
Bacterial vaginosis is associated with prematurity and vaginal fluid mucinase and sialidase: results of a controlled trial of topical clindamycin cream. Am J Obstet Gynecol (1994) 1.57
Micro-affordance: the potentiation of components of action by seen objects. Br J Psychol (2000) 1.55
Performance measures in three rounds of the English bowel cancer screening pilot. Gut (2011) 1.52
Occupational physical activity, socioeconomic status, and risks of 15 cancer sites in Turkey. Cancer Causes Control (1993) 1.51
Analysis of chimeric mRNAs derived from the STE3 mRNA identifies multiple regions within yeast mRNAs that modulate mRNA decay. Nucleic Acids Res (1992) 1.51
The Bristol 'OA500 study': progression and impact of the disease after 8 years. Osteoarthritis Cartilage (2000) 1.50
Epidemiologic features of Strongyloides stercoralis infection in an endemic area of the United States. Am J Trop Med Hyg (1982) 1.49
Objects automatically potentiate action: an fMRI study of implicit processing. Eur J Neurosci (2003) 1.47
Local impact of the English arm of the UK Bowel Cancer Screening Pilot study. Br J Surg (2008) 1.42
Different calcium dependence of the capping and cutting activities of villin. J Biol Chem (1986) 1.41
Ritualised self harm in traditional aboriginal society. Aust N Z J Psychiatry (1994) 1.39
Measurement of chloride concentration in microvolume samples of sweat. Pediatr Pulmonol (1994) 1.39
Increased gene-specific repair of cisplatin interstrand cross-links in cisplatin-resistant human ovarian cancer cell lines. Mol Cell Biol (1992) 1.39
Postoperative radiation therapy after radical prostatectomy for prostate carcinoma. Cancer (1992) 1.38
Orientation-dependent function of a short CYC1 DNA fragment in directing mRNA 3' end formation in yeast. Proc Natl Acad Sci U S A (1988) 1.32
mRNA turnover in yeast promoted by the MATalpha1 instability element. Nucleic Acids Res (1996) 1.26
Induction of ovulation with pulsatile luteinising hormone releasing hormone. Br Med J (Clin Res Ed) (1984) 1.26
A multivariate analysis of factors associated with depression: evaluating the role of health literacy as a potential contributor. Arch Intern Med (2000) 1.26
A demonstration pilot trial for colorectal cancer screening in the United Kingdom: a new concept in the introduction of healthcare strategies. J Med Screen (2001) 1.25
Ability, achievement, and adjustment in homeless children. Am J Orthopsychiatry (1991) 1.25
Modelling potential impacts of bottom trawl fisheries on soft sediment biogeochemistry in the North Sea. Geochem Trans (2001) 1.21
Effects of mutations in the Saccharomyces cerevisiae RNA14, RNA15, and PAP1 genes on polyadenylation in vivo. Mol Cell Biol (1995) 1.20
Biologically active components from mycobacterial cell walls. IV. Protection of mice against aerosol infection with virulent mycobacterium tuberculosis. Cell Immunol (1975) 1.20
Surgical management of ventricular tachycardia in subannular left ventricular aneurysm. Ann Thorac Surg (1995) 1.16
Breast and other cancers in 1445 blood relatives of 75 Nordic patients with ataxia telangiectasia. Br J Cancer (2005) 1.16
Positive outcome after preimplantation diagnosis of aneuploidy in human embryos. Hum Reprod (1999) 1.15
Simplified scoring and psychometrics of the revised 12-item Short-Form Health Survey. Outcomes Manag Nurs Pract (2002) 1.14
TGF-beta in intestinal lymphoid organs contributes to the death of armed effector CD8 T cells and is associated with the absence of virus containment in rhesus macaques infected with the simian immunodeficiency virus. Cell Death Differ (2007) 1.14
Computational identification of cis-acting elements affecting post-transcriptional control of gene expression in Saccharomyces cerevisiae. Nucleic Acids Res (2000) 1.14
Induction of reparative dentine formation in monkeys by recombinant human osteogenic protein-1. Arch Oral Biol (1993) 1.12
Non-disjunction in human sperm: results of fluorescence in situ hybridization studies using two and three probes. Hum Mol Genet (1993) 1.11
A stochastic and deterministic model of medical care utilization. Health Serv Res (1970) 1.10